AKT1 and ovarian cancer: In this study, the effective AKT gene-silencing mediated by the G6 dendrimer nanocarriers (Figure 8a,b) was first verified in SKOV-3 cells, a gold standard model for drug-resistant ovarian cancer, as shown in Figure 8c–f.